There are two types of granulosa cells: those which surround the oocyte are cumulus cells (CC) and those which surround the antrum are mural granulosa cells (MGC). These cells are under the influence of several hormones and growth factors, the most important of which are gonadotrophins and IGF-I. In this article, we report novel observations on the differences between these two types of granulosa cells and their interaction with gonadotrophins and IGF-I. We were able to conduct physiological studies on the role of IGF-I by using an analogue of IGF-I which does not bind to IGF-I-binding proteins (LR 3 -IGF-I). Immature rats received saline, equine chorionic gonadotrophin (eCG), LR 3 -IGF-I or eCG plus LR 3 -IGF-I by infusion using a pump from 24-29 days of age. The rats were killed and the ovaries removed. Surface follicles were punctured and MGC and oocyte cumulus complexes were removed. These were cultured in saline (control) and in three different doses of FSH. Cell replication was assessed by 3 H-thymidine incorporation and differentiation was evaluated by the measurement of progesterone secretion. It was noted that CC replicated ten times more than MGC. Similarly, progesterone secretion by CC was six times more than by MGC. In vivo exposure to gonadotrophins (eCG) positively influenced in vitro treatment with FSH in both cell types. This phenomenon was observed in both cell replication and progesterone secretion. The IGF-I analogue had a positive effect on cell replication of MGC but a negative effect on the cell replication of CC. With respect to progesterone secretion, the IGF-I analogue had a negative effect on CC but a positive effect on MGC. In conclusion, CC behaved differently from MGC in response to gonadotrophins and the IGF-I analogue. IGF-I and FSH acted additively, synergistically or antagonistically in different circumstances.
Introduction
As the Graafian follicle matures, there are several concentric layers of granulosa cells surrounding the oocyte. When the antrum develops and enlarges, the granulosa cells divide into two functional groups: the cells in immediate contact with the oocyte which are called the cumulus cells (cumulus oophorus, CC) and the mural granulosa cells (MGC) which line the follicular wall around the antrum (Greenwald & Terranova 1988) . There has been evidence showing that CC provide nutrition for the oocyte and influence oocyte development in a paracrine fashion (Brower & Schultz 1982 , Moor 1983 . In turn, the oocyte produces materials that influence CC function (Vanderhyden et al. 1990 , Einspanier et al. 1997 , Eppig et al. 1997 . Until recently, all the investigations reported were with MGC but CC play an important role in oocyte maturation and deserve similar meticulous studies. We have therefore conducted a number of studies using bovine, porcine, murine and human models (Xia et al. 1994 , Armstrong et al. 1996 , Khamsi & Armstrong 1997 , Khamsi et al. 1999 , Khamsi & Roberge 2000 which investigated the physiology and pathology of CC.
Initially, gonadotrophins and insulin-like growth factor-I (IGF-I) were investigated as major factors in follicular development. Although this area has been extensively reviewed (Adashi et al. 1985) we wished to use physiological circumstances in our current murine model to compare CC and MGC and their interactions with gonadotrophins and IGF-I. A problem encountered with parenteral administration of IGF-I is that it becomes bound to its circulating binding proteins and is essentially neutralized. We therefore used an analogue of IGF-I, LR 3 -IGF-I, which binds very little to IGF-I-binding proteins and therefore is free to simulate the role of IGF-I in a physiological fashion (Francis et al. 1992 , Ballard et al. 1993 .
Materials and Methods

Animals and in vivo treatments
Immature Sprague-Dawley rats were purchased at 20 days of age (Charles River, St Constant, Canada) and were housed in an animal care facility, maintained on a 14 h light:10 h darkness cycle, and provided with food and water available ad libitum in accordance with guidelines on the handling of laboratory animals. A diagram of the experimental design is presented in Fig. 1 .
At 24 days of age, rats were stratified by body weight into four groups with equal mean body weights. They were then randomized to receive continuous s.c. infusion of an IGF-I analogue, long Arg 3 -IGF-I (LR 3 -IGF-I; Gro-Pep Pty Ltd, Adelaide, Australia) at the rate of 1 mg/kg per day with Alzet mini-osmotic pumps (Alza Corp., Vacavile, CA, USA) or saline. Installation of the pump consisted of one 'jab' of a very fine needle into the subcutaneous tissue. The infusion rate was selected on the basis of previous dose-response studies in rats employing stimulation of growth and anabolic responses as end points of biological efficacy (Francis et al. 1992 , Ballard et al. 1993 . Infusion of LR 3 -IGF-I was continued until the rats were killed at 29 days of age.
At 27 days of age, rats were randomized to receive either an s.c. injection of 15 IU equine chorionic gonadotrophin (eCG; Ayerst, Montreal, Canada) or saline only. The injection was given at 0900 h and the rats were killed (by decapitation) 48 h later which is the equivalent of pro-oestrus for eCG-treated rats.
Rats were weighed immediately before they were killed and their reproductive tracts removed under aseptic conditions. Ovaries of untreated or eCG-treated rats were dissected from the oviducts and adherent adipose and connective tissues, weighed and placed in HEPESbuffered tissue culture medium 199 (HTCM-199; Sigma, St Louis, MO, USA) for recovery of CC and MGC. 
Cell culture and in vitro treatments
Surface follicles (approximately 30 follicles per rat) on the ovaries were punctured with a hypodermic needle and subsequently the ovaries were gently compressed with forceps and agitated in the culture medium to release oocyte cumulus complexes (OCC) and MGC. CC were the cells surrounding the oocyte which were adhered together and to the oocyte. MGC were the loose cells in the follicular fluid. CC had a 'shiny' appearance which was distinct from MGC. Pooled OCC from several rats in each in vivo treatment were rinsed through two successive washes in HTCM-199 and a final rinse in bicarbonatebuffered medium . Ten to fifteen OCC were then transferred at random to each well of a 96-well tissue culture plate (Nalge Nunc International, Napierville, IL, USA) containing BTCM-199. OCC consisted of one oocyte and approximately 30 granulosa cells. Pooled MGC from all rats of the same in vivo treatment were suspended and washed twice in HTCM-199 and resuspended in BTCM-199 after the second wash, with centrifugation at 400 g for 10 min after each wash. The number of MGC was counted with a haemocytometer, and their viability was assessed by trypan blue dye exclusion (Sigma). The final MGC suspension was delivered into wells of a 96-well tissue culture plate and the volume was adjusted to 0·25 ml to give final MGC concentrations of 4 10 5 viable cells/ml. Each culture well received ovine follicle-stimulating hormone (FSH; NIADDKoFSH-17) at one of the following concentrations: 2, 10, 50 ng/ml or no hormone (control). After the addition of the in vitro treatments, CC and MGC were incubated for 20 h in a humidified atmosphere of 5% CO 2 in air at 37·5 C in a water-jacketed tissue culture incubator (Forma Scientific, Marietta, OH, USA). At the end of the incubation period, 1µCi 3 H-thymidine (ICN Biochemicals, Irvine, CA, USA; 20 Ci/mmol) was added to each well and cultures were continued for a further 8 h. Cells were then harvested with a Skatron cell harvester (Fisher Scientific Ltd, Nepean, ON, Canada). Radioactivity not incorporated into DNA was washed off the OCC and MGC by two rinses with BTCM-199. The filter disks containing the cells were air-dried, and incorporated radioactivity was counted with a liquid scintillation spectrometer for the measurement of 3 H-thymidine incorporation. This was interpreted as an index of DNA synthesis.
In vitro dose-response with FSH was performed using six rats per in vivo treatment, and three in vitro replicates per FSH concentration. Progesterone secretion was utilized as an index of steroidogenic differentiation. Progesterone was measured by a specific radioimmunoassay of unextracted aliquots of culture medium removed immediately before the cells were harvested (Leung & Armstrong 1979) . 
Statistical analysis
Six rats were utilized for each in vivo treatment. The OCC were pooled from the six rats and divided into four groups for each of the four in vitro treatments (saline and three different doses of FSH). Each of the aliquots containing a specific dose of FSH was divided into three equal parts and the reading of 3 H-thymidine incorporation was obtained in three different samples. The whole experiment was repeated once more which yielded six readings for each dose group. The data were subjected to analysis of variance (ANOVA) which produced F statistics to compare variation attributed to specific treatment, e.g. LR 3 -IGF-I, eCG etc. with the calculation of random error. We show comparisons in the figures and tables.
Results
Cell replication
Dose-response curve to FSH comparing MGC with CC Table 1 and Fig. 2 show that the baseline 3 H-thymidine incorporation was more than ten times higher in CC than in MGC per cell. Both cell types showed a response to FSH but the dose-response curves were different. With CC, it peaked at 10 ng/ml FSH whereas with MGC it continued to rise up to the highest dose of FSH tested (50 ng/ml). Table 2 and Fig. 2 demonstrate that prior exposure to eCG increased the rate of 3 H-thymidine incorporation at all dose levels of FSH in MGC and most dose levels of FSH in CC. The response curve was different between CC and MGC. With both cell types the dose-response curves flattened after the dose of 10 ng/ml FSH. Table 3 and Fig. 2 demonstrate that prior exposure to IGF-I analogue resulted in quite different responses to FSH in vitro of CC compared with MGC. There was an apparent increase in the MGC, whereas in the CC there was a reduction in 3 H-thymidine incorporation. In the MGC there was a stimulatory effect of the IGF-I analogue which appeared to act synergistically with in vitro FSH. In the CC there was a reduction in cell replication at all dose levels of FSH, i.e. IGF-I analogue in vivo appeared to act antagonistically with in vitro FSH exposure. Table 4 and Fig. 2 , when compared with Table 1 , show a more modest effect of combined LR 3 -IGF-I and eCG compared with eCG alone on MGC replication. This combination also appeared to have a more modest effect than eCG on CC. Looking at the curves, LR 3 -IGF-I plus eCG appeared to reduce the stimulating effect of eCG on CC or MGC proliferation. In vivo exposure to the IGF-I analogue appeared to act antagonistically with respect to gonadotrophin (eCG) also administered in vivo. The curves of eCG alone or eCG plus IGF-I analogue are fairly similar but it is of note that after a dose of 10 ng/ml FSH the response declined. It appears that higher doses of FSH in vitro have a further antagonistic interaction with IGF-I analogue given in vivo.
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Progesterone secretion
Progesterone secretion by CC The results are shown in Fig. 3b . The raw means for CC, displayed for all treatment groups and dosages of FSH, indicated some strong patterns of difference among the three factors (Table 5) . ANOVA (Table 6 ) indicated significant differences among many of the contrasts tested. In particular, the interactions between the dose of FSH compared with eCG or IGF-I were significant at the P<0·001 level. In the presence of an interaction between all three factors, eCG, LR 3 -IGF-I and dose of FSH, one cannot make simple statements about the main effect of any factor. However, the following deductions can be made.
1. Levels of progesterone increased with dose of FSH; the rate of increase was linear with log dose of FSH.
2. Rates of increase were consistently higher when eCG was present than when it was absent (Table 7) .
3. The effect of LR 3 -IGF-I on the slope when eCG was absent was negative; the slope was lower when LR 3 -IGF-I was present than when it was absent. The effect of LR 3 -IGF-I on the slope when eCG was present was positive; the slope was higher when LR 3 -IGF-I was present than when it was absent.
Progesterone secretion by MGC The results are shown in Fig. 3a . The table of means for MGC cells also indicated strong patterns for eCG, LR 3 -IGF-I and dose of FSH (Table 8) . In this instance, however, ANOVA (Table 9 ) indicated no statistically significant interactions except with dose of FSH. The term dose, eCG and IGF-I were not significant, indicating that changes in progesterone secretion for different levels of dose were less complex for MGC than for CC. Also the term eCG or IGF-I were not significant (P=0·057), suggesting that these factors do not modify each other's effects. The following general statements can therefore be made.
1. Increasing doses of FSH increased the level of progesterone secretion in each of the four combinations of treatments (Table 9 ). There was a strong linear component to this change. There was also evidence of significant departure from linearity for all but the eCG group.
2. The presence of eCG was associated with a consistently higher slope.
3. The presence of LR 3 -IGF-I was also associated with a consistently higher slope. The effect of LR 3 -IGF-I was, however, less dramatic than the effect of eCG. The magnitude of these effects could be estimated from the table of means since no interactions have been demonstrated (Table 10) .
Discussion
Innate replication and progesterone secretion of OCC compared with MGC
The first obvious finding was that cell replication, as judged by 3 H-thymidine incorporation, was tenfold higher in CC compared with MGC (comparing Fig. 2a with b) . This phenomenon was in agreement with results of radioautographic studies in rats, in which 3 H-thymidine incorporation in antral follicles was much higher in CC than in MGC (Takaoka et al. 1985 , Hirshfield 1986 ). The same difference between CC and MGC was seen in progesterone secretion when CC (per cell) secreted about sixfold higher levels of progesterone than MGC. Were these differences exclusively related to the different cells or were the CC influenced by the oocyte? We are undertaking further studies removing the oocytes from OCC to investigate the possibilities.
The difference between OCC compared with MGC in their response to in vivo LR 3 -IGF-I treatment
There was a difference as judged by 3 H-thymidine incorporation or progesterone secretion. LR 3 -IGF-I given in vivo increased 3 H-thymidine incorporation and progesterone secretion in MGC whereas it had a reverse effect For definitions of terms see Table 6 . 
